Acute myeloid leukemia occurs when stem cells have a mutation and grow out of control. Smoking and exposure to chemotherapy or radiation are risks.

Clinical data shows that lecanemab (Leqembi) can modestly slow cognitive decline in people with early and mild Alzheimer's disease, but safety issues abound.

Acute myeloid leukemia is treated with chemotherapy, targeted therapy, and supportive treatments. A stem cell transplant may also be needed.

Acute myeloid leukemia survival rates and outlook vary greatly and are affected by age, AML type, and response to treatment.

Learn about the difference between early-onset and late-onset Alzheimer's disease when it comes to hereditary and genetic risks of getting the disease.

Acute myeloid leukemia (AML) is a type of blood cancer primarily affecting older adults. Learn more about how it is diagnosed and how chemotherapy works.

Acute myeloid leukemia (AML) develops rapidly, but it could take years for chronic myeloid leukemia (CML) symptoms to start. Learn about the differences.

Symptoms of acute myeloid leukemia include frequent infections, pale skin, shortness of breath, nose bleeds, abdominal fullness, bruises, and more.

Chronic myeloid leukemia, or CML, may strike at any age but tends to affect adults over age 50. Learn more about its treatment options and prognosis.

Acute myeloid leukemia is not usually hereditary, but the rare subtype familial AML or inherited AML does occur more often in families.